Drugs / ODM-108
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02432664 | Apr 2015 → Apr 2016 | — | Orion Corporation, Orion Pharma | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ODM-108 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02432664 ↗ |
| Route | Oral | “Single oral escalating dose of ODM-108.” NCT02432664 ↗ |